Reduction of allergy burden in preventive and active treatment. Airway hyperresponsiveness, eosinophilia, IgE, goblet cell hyperplasia and Th2 cytokines reduction. IL-10 and CD4+ Foxp3+ regulatory T cells increase. This evidence concerns the gene CD4 and allergic disease.